search
Back to results

Sub-Vastus Versus Mid-Vastus Arthrotomy for Total Knee Arthroplasty: a Randomized Clinical Trial

Primary Purpose

Tricompartmental Gonarthrosis

Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Sub-Vastus arthrotomy
Mid - Vastus arthrotomy
Sponsored by
University Hospital, Ghent
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Tricompartmental Gonarthrosis

Eligibility Criteria

45 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients diagnosed with osteoarthrosis of the knee
  • patients must be in good general health condition

Exclusion Criteria:

  • patients with morbid obesity (BMI >45)
  • patients with history of knee surgery, infection or inflammatory disease of the knee joint or large cartilage lesion

Sites / Locations

  • University Hospital Ghent

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Sub - Vastus arthrotomy

Mid-Vastus arthrotomy

Arm Description

Sub-vastus arthrotomy

Mid-vastus arthrotomy

Outcomes

Primary Outcome Measures

VAS, KOOS and HSS scales
Rehabilitation time; time needed for 90° flexion of the knee joint

Secondary Outcome Measures

VAS, HSS, KOOS questionnaires
Amount and type of analgesic drugs used.

Full Information

First Posted
June 19, 2009
Last Updated
July 5, 2021
Sponsor
University Hospital, Ghent
search

1. Study Identification

Unique Protocol Identification Number
NCT00925626
Brief Title
Sub-Vastus Versus Mid-Vastus Arthrotomy for Total Knee Arthroplasty: a Randomized Clinical Trial
Official Title
Sub-Vastus Versus Mid-Vastus Arthrotomy for Total Knee Arthroplasty: a Randomized Clinical Trial With One Year Follow-up
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Completed
Study Start Date
June 2009 (Actual)
Primary Completion Date
August 2015 (Actual)
Study Completion Date
August 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Ghent

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Randomized, single-blind trial in which one group of patients will be operated with a "Mid-Vastus approach" of the knee joint and the other group will undergo knee surgery with a "Sub-Vastus approach".

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Tricompartmental Gonarthrosis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sub - Vastus arthrotomy
Arm Type
Experimental
Arm Description
Sub-vastus arthrotomy
Arm Title
Mid-Vastus arthrotomy
Arm Type
Active Comparator
Arm Description
Mid-vastus arthrotomy
Intervention Type
Procedure
Intervention Name(s)
Sub-Vastus arthrotomy
Intervention Description
Sub-vastus arthrotomy
Intervention Type
Procedure
Intervention Name(s)
Mid - Vastus arthrotomy
Intervention Description
Mid-vastus arthrotomy
Primary Outcome Measure Information:
Title
VAS, KOOS and HSS scales
Time Frame
at day 1, day 2, day 3, day 4 and day 5 post-operatively
Title
Rehabilitation time; time needed for 90° flexion of the knee joint
Time Frame
post-operatively
Secondary Outcome Measure Information:
Title
VAS, HSS, KOOS questionnaires
Time Frame
at 6 weeks, 3 months and 12 months after surgery.
Title
Amount and type of analgesic drugs used.
Time Frame
pre-operatively and post-operatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: patients diagnosed with osteoarthrosis of the knee patients must be in good general health condition Exclusion Criteria: patients with morbid obesity (BMI >45) patients with history of knee surgery, infection or inflammatory disease of the knee joint or large cartilage lesion
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Verdonk, MD
Organizational Affiliation
University Hospital, Ghent
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospital Ghent
City
Ghent
ZIP/Postal Code
9000
Country
Belgium

12. IPD Sharing Statement

Links:
URL
http://www.uzgent.be
Description
website of the University Hospital Ghent

Learn more about this trial

Sub-Vastus Versus Mid-Vastus Arthrotomy for Total Knee Arthroplasty: a Randomized Clinical Trial

We'll reach out to this number within 24 hrs